시장보고서

상품코드

1908411

심근경색(MI) 치료제 시장(2026-2030년)

Global Myocardial Infarction (Mi) Therapeutics Market 2026-2030

발행일: 2026년 01월 | 리서치사:

TechNavio | 페이지 정보: 영문 290 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심근경색(MI) 치료제 시장은 2025-2030년 23억 1,490만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 4.9%를 보일 것으로 예측됩니다. 본 보고서에서는 세계의 심근경색(MI) 치료제 시장에 관한 종합적 분석, 시장 규모와 예측, 동향, 성장요인, 과제에 함께 약 25개사 벤더 분석을 제공합니다.

본 보고서는 현재 시장 상황, 최신 동향 및 성장요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 이 시장은 전 세계 심혈관 질환 부담 증가와 심근경색 발생률 증가, 의약품 개발의 발전과 심근경색 치료 프로토콜의 혁신, 의료 인프라의 확장, 심장 치료 접근성 향상에 의해 주도되고 있습니다.

이번 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보의 객관적인 조합을 통해 이루어졌습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.

시장 범위
기준 연도	2026년
대상 기간	2030년
예측 기간	2026-2030년
성장 모멘텀	가속
YOY 2026	4.5%
CAGR	4.9%
증가액	23억 1,490만 달러

이 보고서는 향후 몇 년간 세계 심근경색(MI) 치료제 시장의 성장을 견인할 주요 요인 중 하나로 치료 전략에 정밀의료의 통합이 진행되고 있다는 점을 꼽았습니다. 또한, 2차 예방을 위한 병용요법 접근의 확대와 급성기 이후 치료 및 장기적인 질병 관리에 대한 중요성이 증가함에 따라 시장에서 상당한 수요가 창출될 것으로 예측됩니다.

기업 개요
기업 순위 지표
기업의 시장 포지셔닝
Amgen Inc.
AstraZeneca Plc
Bayer AG
Boehringer Ingelheim GmbH
Bristol Myers Squibb Co.
Daiichi Sankyo Co. Ltd.
Eli Lilly and Co.
F. Hoffmann La Roche Ltd.
Idorsia Pharmaceuticals Ltd.
Johnson and Johnson Services
Merck and Co. Inc.
Mesoblast Ltd.
Novartis AG
Pfizer Inc.
Sanofi SA

제16장 부록

LSH 26.01.29

The global myocardial infarction (mi) therapeutics market is forecasted to grow by USD 2314.9 mn during 2025-2030, accelerating at a CAGR of 4.9% during the forecast period. The report on the global myocardial infarction (mi) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of cardiovascular diseases and increasing incidence of myocardial infarction, advancements in drug development and innovation in mi treatment protocols, expanding healthcare infrastructure and improved access to cardiac care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2026
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	4.5%
CAGR	4.9%
Incremental Value	$2314.9 mn

Technavio's global myocardial infarction (mi) therapeutics market is segmented as below:

By Product

Antithrombotics
Vasodilators
Thrombolytics
Others

By End-User

Hospitals
Specialty clinics and ASCs
Others

By Route Of Administration

Oral
Injectable

Geography

North America
- US
- Canada
- Mexico
Asia
Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- The Netherlands
Rest of World (ROW)
Rest of World (ROW)

This study identifies the growing integration of precision medicine in mi treatment strategies as one of the prime reasons driving the global myocardial infarction (mi) therapeutics market growth during the next few years. Also, expansion of combination therapy approaches for secondary prevention and rising emphasis on post-acute care and long-term disease management will lead to sizable demand in the market.

The report on the global myocardial infarction (mi) therapeutics market covers the following areas:

Global myocardial infarction (mi) therapeutics market sizing
Global myocardial infarction (mi) therapeutics market forecast
Global myocardial infarction (mi) therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global myocardial infarction (mi) therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim GmbH, Bristol Myers Squibb Co., CeleCor Therapeutics, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Faraday Pharmaceuticals, Idorsia Pharmaceuticals Ltd., Johnson and Johnson Services, Merck and Co. Inc., Mesoblast Ltd., Novartis AG, Pfizer Inc., Sanofi SA. Also, the global myocardial infarction (mi) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Chart on Market characteristics analysis
3.3 Value chain analysis
- Chart on Value chain analysis

4 Market Sizing

4.1 Market definition
- Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5 Historic Market Size

5.1 Global Myocardial Infarction (MI) Therapeutics Market 2020 - 2024
- Historic Market Size - Data Table on Global Myocardial Infarction (MI) Therapeutics Market 2020 - 2024 ($ million)
5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 The AI Impact on Global Myocardial Infarction (MI) Therapeutics Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2025-2030 (%)
- Data Table on Product - Market share 2025-2030 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Antithrombotics - Market size and forecast 2025-2030
- Chart on Antithrombotics - Market size and forecast 2025-2030 ($ million)
- Data Table on Antithrombotics - Market size and forecast 2025-2030 ($ million)
- Chart on Antithrombotics - Year-over-year growth 2025-2030 (%)
- Data Table on Antithrombotics - Year-over-year growth 2025-2030 (%)
8.4 Vasodilators - Market size and forecast 2025-2030
- Chart on Vasodilators - Market size and forecast 2025-2030 ($ million)
- Data Table on Vasodilators - Market size and forecast 2025-2030 ($ million)
- Chart on Vasodilators - Year-over-year growth 2025-2030 (%)
- Data Table on Vasodilators - Year-over-year growth 2025-2030 (%)
8.5 Thrombolytics - Market size and forecast 2025-2030
- Chart on Thrombolytics - Market size and forecast 2025-2030 ($ million)
- Data Table on Thrombolytics - Market size and forecast 2025-2030 ($ million)
- Chart on Thrombolytics - Year-over-year growth 2025-2030 (%)
- Data Table on Thrombolytics - Year-over-year growth 2025-2030 (%)
8.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
8.7 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Hospitals - Market size and forecast 2025-2030
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
9.4 Specialty clinics and ASCs - Market size and forecast 2025-2030
- Chart on Specialty clinics and ASCs - Market size and forecast 2025-2030 ($ million)
- Data Table on Specialty clinics and ASCs - Market size and forecast 2025-2030 ($ million)
- Chart on Specialty clinics and ASCs - Year-over-year growth 2025-2030 (%)
- Data Table on Specialty clinics and ASCs - Year-over-year growth 2025-2030 (%)
9.5 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Oral - Market size and forecast 2025-2030
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
10.4 Injectable - Market size and forecast 2025-2030
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
10.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2025-2030
  - Chart on US - Market size and forecast 2025-2030 ($ million)
  - Data Table on US - Market size and forecast 2025-2030 ($ million)
  - Chart on US - Year-over-year growth 2025-2030 (%)
  - Data Table on US - Year-over-year growth 2025-2030 (%)
- 12.3.2 Canada - Market size and forecast 2025-2030
  - Chart on Canada - Market size and forecast 2025-2030 ($ million)
  - Data Table on Canada - Market size and forecast 2025-2030 ($ million)
  - Chart on Canada - Year-over-year growth 2025-2030 (%)
  - Data Table on Canada - Year-over-year growth 2025-2030 (%)
- 12.3.3 Mexico - Market size and forecast 2025-2030
  - Chart on Mexico - Market size and forecast 2025-2030 ($ million)
  - Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
  - Chart on Mexico - Year-over-year growth 2025-2030 (%)
  - Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.4 Asia - Market size and forecast 2025-2030
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.4.1 China - Market size and forecast 2025-2030
  - Chart on China - Market size and forecast 2025-2030 ($ million)
  - Data Table on China - Market size and forecast 2025-2030 ($ million)
  - Chart on China - Year-over-year growth 2025-2030 (%)
  - Data Table on China - Year-over-year growth 2025-2030 (%)
- 12.4.2 Japan - Market size and forecast 2025-2030
  - Chart on Japan - Market size and forecast 2025-2030 ($ million)
  - Data Table on Japan - Market size and forecast 2025-2030 ($ million)
  - Chart on Japan - Year-over-year growth 2025-2030 (%)
  - Data Table on Japan - Year-over-year growth 2025-2030 (%)
- 12.4.3 India - Market size and forecast 2025-2030
  - Chart on India - Market size and forecast 2025-2030 ($ million)
  - Data Table on India - Market size and forecast 2025-2030 ($ million)
  - Chart on India - Year-over-year growth 2025-2030 (%)
  - Data Table on India - Year-over-year growth 2025-2030 (%)
- 12.4.4 South Korea - Market size and forecast 2025-2030
  - Chart on South Korea - Market size and forecast 2025-2030 ($ million)
  - Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
  - Chart on South Korea - Year-over-year growth 2025-2030 (%)
  - Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- 12.4.5 Singapore - Market size and forecast 2025-2030
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- 12.4.6 Indonesia - Market size and forecast 2025-2030
  - Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
  - Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
  - Chart on Indonesia - Year-over-year growth 2025-2030 (%)
  - Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- 12.4.7 Thailand - Market size and forecast 2025-2030
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
12.5 Europe - Market size and forecast 2025-2030
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.5.1 Germany - Market size and forecast 2025-2030
  - Chart on Germany - Market size and forecast 2025-2030 ($ million)
  - Data Table on Germany - Market size and forecast 2025-2030 ($ million)
  - Chart on Germany - Year-over-year growth 2025-2030 (%)
  - Data Table on Germany - Year-over-year growth 2025-2030 (%)
- 12.5.2 UK - Market size and forecast 2025-2030
  - Chart on UK - Market size and forecast 2025-2030 ($ million)
  - Data Table on UK - Market size and forecast 2025-2030 ($ million)
  - Chart on UK - Year-over-year growth 2025-2030 (%)
  - Data Table on UK - Year-over-year growth 2025-2030 (%)
- 12.5.3 France - Market size and forecast 2025-2030
  - Chart on France - Market size and forecast 2025-2030 ($ million)
  - Data Table on France - Market size and forecast 2025-2030 ($ million)
  - Chart on France - Year-over-year growth 2025-2030 (%)
  - Data Table on France - Year-over-year growth 2025-2030 (%)
- 12.5.4 Italy - Market size and forecast 2025-2030
  - Chart on Italy - Market size and forecast 2025-2030 ($ million)
  - Data Table on Italy - Market size and forecast 2025-2030 ($ million)
  - Chart on Italy - Year-over-year growth 2025-2030 (%)
  - Data Table on Italy - Year-over-year growth 2025-2030 (%)
- 12.5.5 Russia - Market size and forecast 2025-2030
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- 12.5.6 Spain - Market size and forecast 2025-2030
  - Chart on Spain - Market size and forecast 2025-2030 ($ million)
  - Data Table on Spain - Market size and forecast 2025-2030 ($ million)
  - Chart on Spain - Year-over-year growth 2025-2030 (%)
  - Data Table on Spain - Year-over-year growth 2025-2030 (%)
- 12.5.7 The Netherlands - Market size and forecast 2025-2030
  - Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
  - Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
  - Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
  - Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Australia - Market size and forecast 2025-2030
  - Chart on Australia - Market size and forecast 2025-2030 ($ million)
  - Data Table on Australia - Market size and forecast 2025-2030 ($ million)
  - Chart on Australia - Year-over-year growth 2025-2030 (%)
  - Data Table on Australia - Year-over-year growth 2025-2030 (%)
- 12.6.2 Brazil - Market size and forecast 2025-2030
  - Chart on Brazil - Market size and forecast 2025-2030 ($ million)
  - Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
  - Chart on Brazil - Year-over-year growth 2025-2030 (%)
  - Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  - Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  - Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  - Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
  - Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- 12.6.4 South Africa - Market size and forecast 2025-2030
  - Chart on South Africa - Market size and forecast 2025-2030 ($ million)
  - Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
  - Chart on South Africa - Year-over-year growth 2025-2030 (%)
  - Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- 12.6.5 UAE - Market size and forecast 2025-2030
  - Chart on UAE - Market size and forecast 2025-2030 ($ million)
  - Data Table on UAE - Market size and forecast 2025-2030 ($ million)
  - Chart on UAE - Year-over-year growth 2025-2030 (%)
  - Data Table on UAE - Year-over-year growth 2025-2030 (%)
- 12.6.6 Turkey - Market size and forecast 2025-2030
  - Chart on Turkey - Market size and forecast 2025-2030 ($ million)
  - Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
  - Chart on Turkey - Year-over-year growth 2025-2030 (%)
  - Data Table on Turkey - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Rising global burden of cardiovascular diseases and increasing incidence of myocardial infarction
- Advancements in drug development and innovation in MI treatment protocols
- Expanding healthcare infrastructure and improved access to cardiac care
13.2 Market challenges
- High cost of advanced therapies and economic burden on healthcare systems
- Stringent regulatory requirements and lengthy drug approval processes
- Suboptimal patient adherence and complexity of long-term treatment regimens
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Growing integration of precision medicine in MI treatment strategies
- Expansion of combination therapy approaches for secondary prevention
- Rising emphasis on post-acute care and long-term disease management

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
15.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
15.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.7 Boehringer Ingelheim GmbH
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key news
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
15.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.9 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Business segments
- Daiichi Sankyo Co. Ltd. - Key offerings
- Daiichi Sankyo Co. Ltd. - Segment focus
- SWOT
15.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.12 Idorsia Pharmaceuticals Ltd.
- Idorsia Pharmaceuticals Ltd. - Overview
- Idorsia Pharmaceuticals Ltd. - Product / Service
- Idorsia Pharmaceuticals Ltd. - Key offerings
- SWOT
15.13 Johnson and Johnson Services
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
15.14 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.15 Mesoblast Ltd.
- Mesoblast Ltd. - Overview
- Mesoblast Ltd. - Product / Service
- Mesoblast Ltd. - Key offerings
- SWOT
15.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.18 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

심근경색(MI) 치료제 시장(2026-2030년)

Global Myocardial Infarction (Mi) Therapeutics Market 2026-2030

목차

제1장 주요 요약

제2장 Technavio 분석

제3장 시장 구도

제4장 시장 규모

제5장 시장 규모 실적

제6장 정성 분석

제7장 Five Forces 분석

제8장 시장 세분화 : 제품별

제9장 시장 세분화 : 최종사용자별

제10장 시장 세분화 : 투여 경로별

제11장 고객 상황

제12장 지역별 상황

제13장 성장 촉진요인, 과제 및 기회

제14장 경쟁 구도

제15장 경쟁 분석